Atlas Trials

This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2

Clinical trial NCT03566238 · COMPLETED

Trial details

NCT number
NCT03566238
Sponsor
Albireo
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
PFIC1PFIC2
Start date
2018-05-16
Primary completion
2020-07-27
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.